Helping investors thrive in an evolving world

With our dynamic perspective and meaningful partnership, we instill investor confidence.

Learn how our principles guide us in providing value to our clients and our communities.

Championing an active, independent approach

We’re independent thinkers, united behind an active and rigorous approach, collaborating to identify market risks and opportunities that can give our clients sharper insights and an investment edge.

Firsthand, rigorous research is at the heart of what we do.

We meet regularly with the management teams of the companies we invest in: on-site visits, face-to-face and virtual discussions and attendance at industry and investment conferences. The results: deep relationships that can lead to timely, actionable insights and strong long-term returns for our clients. 

We are in the field and on the lookout. Our embedded experts in 17 markets worldwide access firsthand insights from companies, suppliers and regulators. This means we uncover opportunities that others might miss.

$1.63 trillion assets under management1

With our time-tested investing approach and assets under management, we are one of the top 25 asset management firms in the world.

In turbulent markets, we have you covered.

Our portfolio managers have navigated tough markets, including the tech bubble, the global financial crisis and the coronavirus crisis. That time-tested experience stays with the firm: 57% of our current managers worked in investment roles at T. Rowe Price during the global financial crisis.

Our active management approach takes us beyond the numbers. Over 525 of our investment professionals go out in the field around the world to help us get the answers we need.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      View Transcript

      Ziad / Health Sciences

      Imagine that your disease is going to kill you in less than a year, but a company develops a way to genetically engineer your own blood and your own immune cells to actually recognize the cancer and attack it. Instead of poisoning the cancer cells with toxic chemicals that wreak havoc on the immune system, you tweak the patient’s blood and let the body’s natural immune defense take care of the rest. After medical school in the UK, I worked as an emergency room doctor. What drew me to capital allocation in health sciences was the potential to help many people for years to come through investments that help fund medical innovation. My team and I often choose to invest at the very early stages of human trials, and sometimes when it’s just a concept. It’s exciting to see innovations shift from concept to reality. The human body is made up of proteins. Any disease caused by too much of a bad protein can be controlled or cured by blocking protein production at the cellular level. It’s a priority of mine to go out into the field so I can see firsthand if this is something real. Making the right investment decision is important not only for our investors but for mankind in general—because today’s treatment, which took years to develop, can have long-term future benefits for generations to come. Investing lets me use everything I’ve learned as a doctor, to help make a positive impact on the world. So that’s why I go beyond the numbers.

      Risks: All investments are subject to risks, including the possible loss of principal. Health Science stocks face special risks, including adverse legal or regulatory developments, patent expirations, market competition, and rapidly changing industry dynamics.

      Important Information

      This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested. The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction. Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price. The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. Australia - Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. Canada - Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to Accredited Investors as defined under National Instrument 45-106. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services. DIFC - Issued in the Dubai International Financial Centre by T. Rowe Price International Ltd which is regulated by the Dubai Financial Services Authority as a Representative Office. EEA - Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L-1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. Hong Kong - Issued by T. Rowe Price Hong Kong Limited, 6/F, Chater House, 8 Connaught Road Central, Hong Kong. T. Rowe Price Hong Kong Limited is licensed and regulated by the Securities & Futures Commission. New Zealand - Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013. Singapore - Issued by T. Rowe Price Singapore Private Ltd. (UEN: 201021137E), No. 501 Orchard Rd, #10-02 Wheelock Place, Singapore 238880. T. Rowe Price Singapore Private Ltd. is licensed and regulated by the Monetary Authority of Singapore. Switzerland - Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. UK - This material is issued and approved by T. Rowe Price International Ltd, 60 Queen Victoria Street, London, EC4N 4TZ which is authorised and regulated by the UK Financial Conduct Authority. USA - Issued in the USA by T. Rowe Price Associates, Inc., and T. Rowe Price Investment Services, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which are regulated by the US Securities and Exchange Commission and Financial Industry Regulatory Authority, Inc., respectively. © 2023 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/ or apart, trademarks of T. Rowe Price Group, Inc.

      202309- 3094347

      Pursuing performance with principle

      We’re committed to our clients’ success. That’s why we maintain a long-term view as we aim to deliver consistently strong performance for investors in up and down markets.

      Better investment decisions begin with our active management approach

      With a principled commitment to client success, we aim for strong long-term investment results, through any market environment. So, you can feel more confident about reaching your most important goals. 

      We were founded on a client-first mindset.

      From the moment we began, our clients came first. When he founded the company in 1937, Thomas Rowe Price, Jr., resolved that integrity would be the firm’s guiding principle.

       

      We’ve managed investments through all kinds of markets. We know that identifying risks is as important as identifying opportunities. 

      97% retention rate

      Our portfolio managers average 23 years in the industry, with a 97% retention rate. Clients can rely on us for deep knowledge and experience. 

      Our emerging markets team has investment professionals from 26 nationalities speaking 28 languages.
      Samy Muaddi, CFA® Head of Emerging Markets
      Samy Muaddi is a Portfolio Manager in the International Fixed Income Division, focused on emerging markets.
      avatar

      Building meaningful partnerships

      We create deep partnerships. By understanding clients’ needs and delivering timely, actionable insights and solutions, we help them navigate change and achieve better outcomes.

      Our digital platforms give you direct access to unique insights from analysts and portfolio managers.

      In 17 markets around the globe, we work with a broad range of clients—from individuals to financial advisors to institutions to retirement plan sponsors.

      We invest in our communities to improve outcomes.

      We commit to making a positive impact in the community and serving as a trusted partner. We collaborate with nonprofit and community leaders to understand areas of greatest need. And we invest in solutions that improve outcomes for youth, empower individuals and enrich communities. 

      32,000 associate volunteer hours in our communities

      Our associates value the opportunity to partner with our communities and give back. Their efforts include: more than 32,000 associate hours volunteered globally, 368 associates serving on 440 nonprofit boards, and USD 15.3 million donated to communties.

      Driving deliberate innovation

      To meet the evolving needs of our clients, we create investment solutions and services in a way that’s forward-thinking and purposeful.

      Skip timeline

      Today

      Now and the future

      We’re looking ahead, anticipating the emerging needs of today’s investors. 

      2021

      Alternative credit markets

      The 2021 acquisition of Oak Hill Advisors, L.P. (OHA), accelerates our expansion into alternative credit markets. The move reflects our deliberate, thoughtful approach to advancing our capabilities to drive value for our clients.

      2017

      Innovative data tools empower investment professionals

      Our Technology Development Center (TDC) in New York City opens, attracting world-class talent with expertise in big data, machine learning and predictive analytics, dedicated to bringing data-driven insights to our investment professionals.

      1985

      Emerging markets

      We begin investing in emerging markets, more than 15 years before the launch of the MSCI Emerging Markets Index. Five years later, we launch our first dedicated emerging markets strategy in 1990.

      1960

      Small-cap pioneer

      Pre-dating the Russell 2000 Index, T. Rowe Price packages its small-cap investing prowess for clients. The firm focuses on small, rapidly growing companies, supported by quantitative analysis.

      1950

      An early growth stock leader

      We start one of the first US growth stock funds, stemming from our founder’s early emphasis on finding companies with strong, long-term earnings potential.

      1937

      The firm launches

      Thomas Rowe Price, Jr., sets out to create an organization “with a reputation for the highest character and the soundest investment philosophy.” Instead of charging clients commissions for investments, we charged fees based on assets—an approach that ensured the clients’ interests came first.

      We put our clients at the center of our best thinking.

      Better questions. Better Insights. T. Rowe Price helps you see what’s ahead, what’s most important, and how our investment teams are responding now. 

      Capabilities to meet a full range of investor needs

      Asset class figures shown represent total assets under management of USD $1.63 trillion as of 30 September, 2024. All amounts shown in U.S. dollars and subject to change.

      Equity

      $832.0 b

      Assets under management

      Fixed Income

      $186.3 b

      Assets under management

      Multi-Asset

      $560.9 b

      Assets under management

      Alternatives

      $51.7 b

      Assets under management

      A destination for all our clients

      I’m an institutional investor or consultant looking to review investment strategies and discover timely insights. 

      I'd like to learn more about T. Rowe Price, the company, its culture and business priorities. 

      Important Information

      (All data as of 31 December 2022, unless otherwise noted. Firmwide assets under management include assets managed by T. Rowe Price Associates, Inc., and its investment advisory affiliates. All amounts shown in US dollars.)

      ¹Figure shown is as of March 31, 2024. Subject to adjustment.
      ²Top Asset Management Firms ranked by total AUM as of 31 March 2023, compiled by ADV Ratings (advratings.com/top-asset-management-firms)
      Source: T. Rowe Price press release, April 2023.